JPM
JPMorgan Chase & Co.
JPM has slightly lower modeled downside risk, despite its lower overall score.
MORN
Morningstar, Inc.
MORN has the edge over JPM overall, supported by stronger valuation and stronger modeled upside.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
MORN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
MORN's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like MORN.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
MORN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 17x | $246 | — |
| Current | 22x | $246 | — |
| Cheap | 26x | $298 | +21% |
| Fair | 48x | $549 | +123% |
| Expensive | 88x | $999 | +306% |
Historical ranges are pointers, not guarantees.
MORN has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
MORN Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
MORN has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
MORN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $14.12 | +24% |
| Q3 2026 | $11.41 | +30% |
| Q2 2026 | $10.52 | +12% |
| Q1 2026 | $9.78 | +9.8% |
| Q4 2025 | $8.87 | +3.4% |
| Q3 2025 | $8.80 | +16% |
| Q2 2025 | $9.40 | +64% |
| Q1 2025 | $8.91 | +80% |
| Q4 2024 | $8.58 | +161% |
MORN has the edge over JPM on earnings, with stronger typical year-over-year growth.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over MORN on profitability, with a higher operating margin.
MORN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $672.1M | +8.9% |
| Q2 2026 | $663.2M | +9.6% |
| Q1 2026 | $644.8M | +11% |
| Q4 2025 | $641.1M | +8.5% |
| Q3 2025 | $617.4M | +8.4% |
| Q2 2025 | $605.1M | +5.8% |
| Q1 2025 | $581.9M | +7.2% |
| Q4 2024 | $591M | +9.7% |
MORN has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 25% | +4.2 points |
| Q2 2026 | 24% | +3.5 points |
| Q1 2026 | 24% | +4.6 points |
| Q4 2025 | 25% | -3.6 points |
| Q3 2025 | 21% | +0.4 points |
| Q2 2025 | 21% | +1.7 points |
| Q1 2025 | 20% | +2.6 points |
| Q4 2024 | 28% | +11 points |
MORN's operating margin was 25% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
MORN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $155.4M | -2.9% |
| Q2 2026 | $122.5M | +96% |
| Q1 2026 | $53.6M | -8.8% |
| Q4 2025 | $161.3M | +43% |
| Q3 2025 | $160.1M | +2.8% |
| Q2 2025 | $62.4M | -48% |
| Q1 2025 | $58.8M | -1.2% |
| Q4 2024 | $112.8M | +4.6% |
MORN has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has 2.7B diluted shares, down 3.1% from a year ago, with $24.5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
MORN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -300K shares |
| 1 year | -11% | -4.5M shares |
| 3 years | -12% | -5.1M shares |
| 5 years | -13% | -5.6M shares |
| Available history | -13% | -5.5M shares |
MORN has the edge over JPM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $100M |
| Q2 2026 | $100M |
| Q1 2026 | $300M |
| Q4 2025 | $395.3M |
| Q3 2025 | $170.1M |
| Q2 2025 | $112M |
| Q1 2025 | $109.6M |
| Q4 2024 | $11.6M |
MORN spent $895M buying back its own shares over the past year, up 122% from the year before.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over MORN on leverage, with a lower net debt burden relative to earnings.
MORN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.4x | Healthy |
| Q2 2026 | 1.6x | Healthy |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 0.8x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.4x | Very low |
| Q4 2024 | 0.3x | Very low |
MORN's net debt is about 1.4 years of its operating earnings (EBITDA), up from less than a year a year ago. Net leverage isn't a meaningful measure for financial services companies like MORN.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
MORN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.0 | Neutral |
| Stochastic | 94.7 | Overbought |
MORN's weekly RSI is 67 (neutral) and its Stochastic is 95 (overbought).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over MORN on valuation relative to its sector.
MORN PE vs Financial Services Sector
| Metric | MORN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 13x | 66% above |
| PE % | 11 | 63 | 52 pts below |
MORN is trading at 22x earnings, a 66% premium to the Financial Services sector's median of 13x.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
MORN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $216.6 | 14% above |
| 20 week MA | $202.4 | 22% above |
| 50 week MA | $191.9 | 28% above |
| 100 week MA | $236.4 | 4.1% above |
| 200 week MA | $251.9 | 2.3% below |
MORN has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 2.3% below its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
MORN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $152.0 | $222.3 | +46% |
| 2021 | $222.3 | $339.5 | +53% |
| 2022 | $339.5 | $213.5 | -37% |
| 2023 | $213.5 | $286.2 | +34% |
| 2024 | $286.2 | $339.8 | +19% |
| 2025 | $339.8 | $219.1 | -36% |
| 2026 YTD | $219.1 | $246.1 | +12% |
MORN has the edge over JPM on returns for 2026, with the stronger performance.